Amid Rising Opposition, Elevance Pauses Deal to Buy Louisiana Blues

Elevance Health, Inc.’s planned acquisition of Blue Cross and Blue Shield of Louisiana (BCBSLA) has been put on hold as political opposition to the deal intensifies. The deal, which was announced in January, was already troubled due to investigations by state regulators and a bipartisan uproar from state elected officials. One managed care insider says macroeconomic conditions likely have redoubled considerable opposition to the deal from providers and other stakeholders.

The New Orleans Times-Picayune reported that BCBSLA leaders met with Republican Attorney General Jeff Landry, a frontrunner in the ongoing gubernatorial race in Louisiana, on Sept. 18. The attorney general hopes that the deal will be delayed until the new governor and insurance commissioner take office, according to the newspaper. (Jim Donelon, the incumbent Republican commissioner, plans to retire.)

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

louisiana
September 1

Regulators, Providers Push Back on Elevance’s Deal to Buy Louisiana Blues

READ MORE
businessmen-shaking-hands
January 27

Elevance-BCBS of Louisiana Deal, by the Numbers

READ MORE
anthem-building
March 3

Though Appeals Persist, Blue Cross Blue Shield Antitrust Settlement May Already Be Having Impact

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today